<p>(A) shows wild-type (ERK1/ERK2) or phosphorylated ERK 1/2 (P-ERK1/ERK2) during exposure to progesterone (100 nM). (B) Shows wild-type (Akt) and phosphorylated Akt (P-Akt) in the presence of 100 nM P. (C) T47-D cells were transfected with scrambled siRNA or ERK1/2 targeted siRNAs for 48 h. After that level of ERK1/2 protein expression was detected by western blot as indicated. (D) Cells were exposed to 100 nM P or MPA for 15 min after transfection with 100 nM targeted siRNA for ERK1/2 or scrambled siRNA for 48 h. Cell contents of wild-type or phosphorylated moesin are shown. (E) Cells were exposed to 100 nM progesterone or MPA for 15 min after transfection with constitutively active p85α (WT p85α) or dominant-negative p85α (Δp85α) for 48 ...
(B) Shows the concentration/effect curve of each progestin on moesin phosphorylation over a range of...
<p>(A) HK-2 cells that were treated with or without TGF-β1 (5 ng/ml) as well as Erk phosphorylation ...
<p>(A) T47-D cells were treated with E2 (10<sup>−8</sup> M) or E-BSA (10<sup>−8</sup> M) for 15 min,...
<p>(A) T47-D cells were treated with progesterone or MPA (both 100 nM) for 15 min, in the presence o...
<p>(A) and (B) T47-D cells were exposed for 15 min to progesterone or MPA (both 100 nM) in the prese...
<p>(A) T47-D cells were treated for 15 minutes with P or MPA (both 100 nM), in the presence or absen...
<p>T47-D (A and D) , MCF-7 (B and E) or MDA-MB-468 (C) cells were treated for 15 minutes with either...
<p>(A), (B) (C) and (D) show the time- and dose-dependent moesin activation in T47-D breast cancer c...
<p>T47-D (A) or MCF-7 (B) cells were exposed for 15 min to 10 nM E2 or to E2 conjugated to bovine se...
<p>(A) and (B) T47-D cells were treated with progesterone or MPA (both 100 nM) for 24 h, in the pres...
<p>(A-B)Vero cells were transfected with pcDNA3.1-p17 or pcDNA3.1 (vector only) for 24 hours. The re...
<p>(A) MDM were treated with R5 gp120 (3 µg/ml) for the indicated time periods or left untreated (co...
The MAPK/ERK1/2 serine kinases are primary mediators of the Ras mitogenic signaling pathway. Phospho...
<p>(A) and (B) Cells were treated with progesterone or MPA (both 100 nM) for 48 h, in the presence o...
<p>A) Representative fields of fibroblast treated for 24 hr with 10% serum. In this example, cells h...
(B) Shows the concentration/effect curve of each progestin on moesin phosphorylation over a range of...
<p>(A) HK-2 cells that were treated with or without TGF-β1 (5 ng/ml) as well as Erk phosphorylation ...
<p>(A) T47-D cells were treated with E2 (10<sup>−8</sup> M) or E-BSA (10<sup>−8</sup> M) for 15 min,...
<p>(A) T47-D cells were treated with progesterone or MPA (both 100 nM) for 15 min, in the presence o...
<p>(A) and (B) T47-D cells were exposed for 15 min to progesterone or MPA (both 100 nM) in the prese...
<p>(A) T47-D cells were treated for 15 minutes with P or MPA (both 100 nM), in the presence or absen...
<p>T47-D (A and D) , MCF-7 (B and E) or MDA-MB-468 (C) cells were treated for 15 minutes with either...
<p>(A), (B) (C) and (D) show the time- and dose-dependent moesin activation in T47-D breast cancer c...
<p>T47-D (A) or MCF-7 (B) cells were exposed for 15 min to 10 nM E2 or to E2 conjugated to bovine se...
<p>(A) and (B) T47-D cells were treated with progesterone or MPA (both 100 nM) for 24 h, in the pres...
<p>(A-B)Vero cells were transfected with pcDNA3.1-p17 or pcDNA3.1 (vector only) for 24 hours. The re...
<p>(A) MDM were treated with R5 gp120 (3 µg/ml) for the indicated time periods or left untreated (co...
The MAPK/ERK1/2 serine kinases are primary mediators of the Ras mitogenic signaling pathway. Phospho...
<p>(A) and (B) Cells were treated with progesterone or MPA (both 100 nM) for 48 h, in the presence o...
<p>A) Representative fields of fibroblast treated for 24 hr with 10% serum. In this example, cells h...
(B) Shows the concentration/effect curve of each progestin on moesin phosphorylation over a range of...
<p>(A) HK-2 cells that were treated with or without TGF-β1 (5 ng/ml) as well as Erk phosphorylation ...
<p>(A) T47-D cells were treated with E2 (10<sup>−8</sup> M) or E-BSA (10<sup>−8</sup> M) for 15 min,...